Troxipide dispersible tablet and preparation method thereof
A technology of traxipide and dispersible tablets, applied in the field of medicine, can solve the problems of single taking method and long disintegration time, and achieve the effects of high bioavailability, short disintegration time and improving compliance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0016] Example 1. Selection of disintegrant
[0017] Choose PVPP (cross-linked polyvinylpyrrolidone), CMS-Na (sodium carboxymethyl starch), LS-HPC (low-substituted hydroxypropyl cellulose) as disintegrants, the dosage is 15%, each before and after granulation Add half, and then check the appearance and pink uniformity of the tablets. The results are shown in Table 1.
[0018] Table 1. Preliminary selection of disintegrants
[0019]
[0020] For the four tablets prepared, the disintegrant LS-HPC in prescription 3 has almost no disintegration effect; when prescription 2 disintegrates, the surface layer disintegrates faster, and the inner layer is more difficult to disintegrate, but the tablet The appearance of the agent is the best; the disintegrant added in prescription 1 has a greater effect, but the appearance is loose and there are cracks; the appearance and dispersion uniformity of prescription 4 meet the requirements, which is the better solution.
Embodiment 2
[0021] Example 2. Selection of adhesive
[0022] Based on the selection of filler MCC (microcrystalline cellulose) and disintegrant PVPP (cross-linked polyvinylpyrrolidone), CMS-Na (carboxymethyl starch sodium), the concentration of the binder was investigated, and the dispersion uniformity was the main Index, tablet appearance compressibility is a secondary index to choose the best prescription. The results are shown in Table 2.
[0023] Table 2. Selection of binder concentration
[0024]
[0025] Note: Dispersion uniformity (s) measurement method: Take 2 pieces of the test product, place them in 100ml water at 20℃±1℃, shake, and record the total disintegration time.
[0026] It can be seen from Table 2 that considering the uniformity of tablet dispersion, appearance, and compressibility, the most preferred 2% PVPk30 aqueous solution is the binder.
Embodiment 3
[0027] Example 3. Preparation of Trixipide Dispersible Tablets A
[0028] Prescription: Trixipide 100g
[0029] Microcrystalline cellulose 120g
[0030] Sodium Carboxymethyl Starch 10g
[0031] Cross-linked polyvinylpyrrolidone 30g
[0032] Magnesium stearate 1.3g
[0033] Micronized silica gel 1.3g
[0034] Take the prescription amount of trexipide, microcrystalline cellulose, cross-linked polyvinylpyrrolidone and sodium carboxymethyl starch, sieving and mixing, and use 60mL of 1% PVPk30 aqueous solution (concentration unit is g / mL, that is, 1g PVPk30 is dissolved in 100mL water, the same below) make soft material, granulate with 20 mesh nylon sieve, dry for 2h at 70℃, granulate with 24 mesh nylon sieve, then add micronized silica gel and magnesium stearate and mix well, determine content, press tablet, and pass the inspection package.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com